Evidence map›Paper›PMID 42769928›Full record

ReviewFrontiers in immunology2026

Evolving role of CD8

Fatemeh Sadat Tabatabaei, Shannon K Bromley

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatemeh Sadat TabatabaeiCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Shannon K BromleyCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Funding

Effect of Th2-type microenvironment on CD8 TRM-mediated protection from infectionR01AI163517 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SHANNON K BROMLEY · 2022 to 2026
$2.9M
NIAID NIH HHS R01 AI163517
6 · The paper itself

Abstract

Memory CD8

Indexed as

Autoimmune DiseasesCD8-Positive T-LymphocytesImmune System DiseasesImmunologic MemoryInflammationMemory T CellsAnimalsCytokinesHumansCytokinesadaptive immunityautoimmunityCD103CD49aCD69chronic inflammationskin diseaseT cells

Identifiers

PMID42769928
PMCPMC13591607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.